Recent News
Whistleblower Receives $1.8 Million In Hospital False Claims Act Settlement
A former director of Health Management Services at Morton Plant Hospital will receive over $1.8 million as her share of the government’s recovery in a False Claims Act case arising from a hospital group’s submission of false claims for services rendered to Medicare...
Improper Payments To Skilled Nursing Facilities Cost Medicare $1.5 Billion In 2009
The Office of Inspector General for the U.S. Department of Health and Human Services recently conducted a study that identified errors in 25 percent of the claims submitted by skilled nursing facilities in 2009, resulting in $1.5 billion in inappropriate Medicare...
OIG Reports That Diabetes Test Suppliers Improperly Billed Medicare
In a recent report, the Office of Inspector General for the U.S. Department of Health and Human Services found that suppliers improperly billed Medicare for more expensive diabetes test strips. The study focused on practices that included (1) improperly billing mail...
OIG Study Finds That Medicare Contractors Lacked Controls To Prevent Millions In Improper Payments For Blood-Glucose Test Strips
The Office of Inspector General (OIG) recently conducted a review of contractors that process claims for home blood-glucose test strip and lancet supplies. Medicare Part B covers test strips and lancets prescribed by physicians for diabetics. This coverage depends...
Ex-Bayer Salesman Wins Award In FCA Retaliation Suit
Ex-Bayer Salesman Wins Award In FCA Retaliation Suit By Keith Goldberg Law360, New York (November 05, 2012, 3:52 PM ET) -- An Arkansas federal jury on Friday awarded a former Bayer Corp. sales representative nearly $900,000 after finding that the company fired him in...
Missouri Hospital System Agrees to Pay $9.3 Million to Resolve False Claims Act and Stark Law Violations
Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Monday, November 5, 2012 Missouri Hospital System Agrees to Pay $9.3 Million to Resolve False Claims Act and Stark Law Violations Hospital Allegedly Improperly Compensated Physicians for Referrals...
Pfizer discloses $491M charge for Rapamune marketing settlement
Pfizer has disclosed a $491 million charge for a Rapamune marketing settlement, fiercepharma.com reports, citing Dow Jones. The company made a deal with the US Justice Department to resolve the long-standing probe, which Pfizer inherited when it bought Wyeth in 2009....
Omeros Settles Wrongful Termination Suit With Former CFO for $3.9M
Omeros, the Seattle-based drug developer, has ended a long-running dispute with former chief financial officer Richard Klein by agreeing to pay him $3.94 million to settle a wrongful termination case he brought against the company three years ago. Omeros (NASDAQ:...
Orthofix Subsidiary, Blackstone Medical, Pays U.S. $30 Million to Settle False Claims Act Allegation
Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Friday, November 2, 2012 Orthofix Subsidiary, Blackstone Medical, Pays U.S. $30 Million to Settle False Claims Act Allegations Allegedly Paid Kickbacks to Doctors to Induce Use of Company’s...
United States Sues Virginia-based Contractor for False Claims Under Contract for Security in Iraq
Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Wednesday, October 31, 2012 United States Sues Virginia-based Contractor for False Claims UnderContract for Security in Iraq - Allegedly Billed US for Security Guards Who Did Not Meet Contract...
Texas secures $19.9M Novartis agreement over Medicaid fraud allegations
Austin Business Journal by Sarah Drake, Web Editor Date: Tuesday, October 30, 2012 The Texas Attorney General’s office has come to a $19.9 million agreement with Swiss pharmaceutical drug company Novartis over the alleged deceptive marketing of a topical skin cream...
Boehringer Ingelheim to Pay $95 Million to Resolve False Claims Act Allegations
Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Thursday, October 25, 2012 Government Alleges Company Improperly Marketed Three Drugs Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $95 million to resolve allegations...